Shawn Alter

859 total citations
9 papers, 631 citations indexed

About

Shawn Alter is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Shawn Alter has authored 9 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Shawn Alter's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Shawn Alter is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Shawn Alter collaborates with scholars based in United States, Israel and Canada. Shawn Alter's co-authors include Gary W. Miller, David S. Goldstein, Jason R. Stephenson, Randy A. Hall, Kevin J. Paavola, Minzheng Wang, Alison I. Bernstein, Yehonatan Sharabi, Randy Strong and Courtney Holmes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neurochemistry.

In The Last Decade

Shawn Alter

9 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn Alter United States 9 329 278 246 65 53 9 631
P.-A. Löschmann Germany 12 230 0.7× 310 1.1× 116 0.5× 80 1.2× 86 1.6× 14 607
Kalpita Banerjee United States 11 139 0.4× 301 1.1× 152 0.6× 53 0.8× 184 3.5× 14 619
James P. Finn United States 11 368 1.1× 601 2.2× 101 0.4× 87 1.3× 72 1.4× 15 940
Nelly E. Villacreses United States 13 158 0.5× 278 1.0× 95 0.4× 18 0.3× 102 1.9× 17 686
M. Finesso Italy 13 323 1.0× 302 1.1× 116 0.5× 55 0.8× 129 2.4× 22 761
Fabrizio Pontarelli United States 12 410 1.2× 514 1.8× 379 1.5× 51 0.8× 142 2.7× 17 1.1k
Francesca-Fang Liao United States 11 129 0.4× 377 1.4× 72 0.3× 101 1.6× 228 4.3× 13 646
Márcio Ribeiro Portugal 17 474 1.4× 590 2.1× 137 0.6× 33 0.5× 141 2.7× 26 907
Tatyana Kareva United States 12 373 1.1× 297 1.1× 280 1.1× 47 0.7× 68 1.3× 17 665
Frédéric Dessi France 15 499 1.5× 543 2.0× 61 0.2× 80 1.2× 157 3.0× 23 927

Countries citing papers authored by Shawn Alter

Since Specialization
Citations

This map shows the geographic impact of Shawn Alter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn Alter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn Alter more than expected).

Fields of papers citing papers by Shawn Alter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn Alter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn Alter. The network helps show where Shawn Alter may publish in the future.

Co-authorship network of co-authors of Shawn Alter

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn Alter. A scholar is included among the top collaborators of Shawn Alter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn Alter. Shawn Alter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Stout, Kristen A., Amy R. Dunn, Kelly M. Lohr, et al.. (2016). Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice. ACS Chemical Neuroscience. 7(10). 1364–1373. 29 indexed citations
2.
Alter, Shawn, Kristen A. Stout, Kelly M. Lohr, et al.. (2015). Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. 275. 17–24. 15 indexed citations
3.
Lohr, Kelly M., Alison I. Bernstein, Kristen A. Stout, et al.. (2014). Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences. 111(27). 9977–9982. 154 indexed citations
4.
Yu, Bing, Wei Liu, Wen-Mei Yu, et al.. (2013). Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11 -Associated Malignancies. Molecular Cancer Therapeutics. 12(9). 1738–1748. 40 indexed citations
5.
Goldstein, David S., Patti Sullivan, Courtney Holmes, et al.. (2013). Determinants of buildup of the toxic dopamine metaboliteDOPALin Parkinson's disease. Journal of Neurochemistry. 126(5). 591–603. 153 indexed citations
6.
Taylor, Tonya, Shawn Alter, Minzheng Wang, David S. Goldstein, & Gary W. Miller. (2013). Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76. 97–105. 51 indexed citations
7.
Alter, Shawn, Gina M. Lenzi, Alison I. Bernstein, & Gary W. Miller. (2013). Vesicular Integrity in Parkinson’s Disease. Current Neurology and Neuroscience Reports. 13(7). 362–362. 34 indexed citations
8.
Paavola, Kevin J., et al.. (2011). The N Terminus of the Adhesion G Protein-coupled Receptor GPR56 Controls Receptor Signaling Activity. Journal of Biological Chemistry. 286(33). 28914–28921. 136 indexed citations
9.
Zheng, Hong, et al.. (2009). SHP-2 tyrosine phosphatase in human diseases.. PubMed. 2(1). 17–25. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026